IMMUNOMEDICS IN COLLABORATION WITH ALGETA TO EVALUATE POTENTIAL OF EPRATUZUMAB CONJUGATED TO ALPHA-EMITTER THORIUM-227

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. more

View todays social media effects on IMMU

View the latest stocks trending across Twitter. Click to view dashboard

See who Immunomedics is hiring next, click here to view